In sorafenib-resistant HCC cells, METTL3 is significantly downregulated, leading to FOXO3 degradation, thus promoting autophagy-induced resistance to sorafenib in HCC [30]. This evidence concerns the gene METTL3 and hepatocellular carcinoma.